Recent News

• 04.11.2025 - April 11, 2025 - April 15, 2025 : ESCMID –  Congress of the European Society of Clinical Microbiology and Infectious Diseases 2025
• 04.11.2025 - April 11, 2025 - April 15, 2025 : ESCMID –  Congress of the European Society of Clinical Microbiology and Infectious Diseases 2025
• 04.09.2025 - Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress
• 04.09.2025 - Assembly Biosciences Presents New Data Highlighting Long-Acting Herpes Simplex Virus Candidate ABI-5366 and Genital Herpes Prevalence and Treatment Patterns at the 2025 ESCMID Congress
• 03.20.2025 - Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights
• 03.20.2025 - Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights
• 03.20.2025 - Assembly Biosciences Reports Year End 2024 Financial Results and Recent Highlights
• 02.26.2025 - Assembly Biosciences Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus
• 02.26.2025 - Assembly Biosciences Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus
• 02.20.2025 - Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor ABI-1179 in Development for Recurrent Genital Herpes

Recent Filings

• 04.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2025 - EFFECT Notice of Effectiveness
• 04.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.01.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.20.2025 - EX-99.1 EX-99.1
• 03.20.2025 - 8-K Current report
• 03.20.2025 - S-3 Registration statement under Securities Act of 1933
• 03.20.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]